Akums Drugs and Pharmaceuticals Limited has announced the resumption of manufacturing operations at its Haridwar facilities following a period of industry-wide labour unrest. As of May 16, 2026, production has successfully restarted at over 70% capacity. The disruption, which stemmed from a state-wide review of minimum wages in Uttarakhand, did not impact other company locations. Management expects productivity to improve progressively as normal operations are fully restored.
Operations Update
Following a recent industry-wide labour disruption in the state of Uttarakhand, Akums Drugs and Pharmaceuticals has confirmed that its manufacturing units in Haridwar have begun returning to normal activity. Operations reached the 70% capacity threshold effective May 16, 2026. The company stated that production levels are anticipated to increase steadily in the coming days as the situation continues to stabilize.
Impact Assessment
The company has clarified that there has been no physical damage to its property as a result of the labour unrest. While the event caused a temporary loss of production, the company maintains industrial insurance coverage for such interruptions. The process for assessing and claiming insurance benefits is currently underway and will be completed in due course.
Business Continuity
It is important to note that the operational disruptions were localized to specific units in Haridwar. Manufacturing at the company’s other facilities across India remained stable and continued to operate without interruption throughout the period. Local authorities are currently coordinating with industries throughout the region to ensure full restoration of normalcy and long-term stability for manufacturing activities.
Source: BSE
